Skip to main content

Compliance & Legal

By Jeff Lagasse | 11:43 am | July 15, 2024
The defendants allegedly caused the hospital to pay vendors for goods and services they knew had not been provided.
By HIMSS TV | 07:00 am | July 10, 2024
Zubin Khambatta, a healthcare attorney and partner at Holland & Knight, unpacks the rule, which was to go into effect on July 9 but has been challenged by the state of Texas.  
By HIMSS TV | 05:16 pm | July 08, 2024
Celo's HIPAA-compliant messaging app allows care teams to share information easily without compromising patients' privacy. Jack Clough, the company's chief growth officer, shares more about the technology.  
By Mike Miliard | 11:35 am | July 08, 2024
While the healthcare group "strongly supports" CIRCIA's security goals, it's urging the Homeland Security agency to "consider the challenges covered entities face during and immediately after experiencing a cyberattack."
By Mike Miliard | 10:21 am | July 02, 2024
C-suite leaders and other executives from EHR, analytics, clinical automation and managed services firms see enforcement of the new Cures Act final rule as an overdue "step in the right direction."
By Andrea Fox | 11:59 am | June 25, 2024
Not only are the HHS information blocking disincentives too steep, but they could also interrupt accountable care organizations' shift to value-based care, the organizations argue. Meanwhile, the EHR Association says the regs are "too narrowly focused."
By Susan Morse | 12:04 pm | June 24, 2024
Final rule disincentives include hospitals not being able to earn three quarters of the annual market basket increase.
By Susan Morse | 11:37 am | June 24, 2024
The employee, reportedly an executive who was an interim medical director, allegedly misrepresented her qualifications.
By Adam Ang | 02:43 am | June 18, 2024
Also, South Australia is introducing free virtual mental health support for young people.
By Jessica Hagen | 11:48 am | June 14, 2024
The telemedicine company's clinical president and its founder and CEO allegedly participated in a scheme to profit from providing easy access to Adderall for no valid medical purpose.